| Basics |
|
Nexalin Technology, Inc.
|
| IPO Date: |
September 12, 2022 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$18.09M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.08 | 6.29%
|
| Avg Daily Range (30 D): |
$0.04 | 3.54%
|
| Avg Daily Range (90 D): |
$0.05 | 4.60%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.66M |
| Avg Daily Volume (30 D): |
.2M |
| Avg Daily Volume (90 D): |
2.24M |
| Trade Size |
| Avg Trade Size (Sh.): |
239 |
| Avg Trade Size (Sh.) (30 D): |
188 |
| Avg Trade Size (Sh.) (90 D): |
246 |
| Institutional Trades |
| Total Inst.Trades: |
1 |
| Avg Inst. Trade: |
$.74M |
| Avg Inst. Trade (30 D): |
$.74M |
| Avg Inst. Trade (90 D): |
$.74M |
| Avg Inst. Trade Volume: |
.27M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.66
|
$-.13
|
$-.1
|
|
Diluted EPS
|
$-.66
|
$-.13
|
$-.1
|
|
Revenue
|
$ .16M
|
$ .02M
|
$ .07M
|
|
Gross Profit
|
$ .11M
|
$ .01M
|
$ .05M
|
|
Net Income / Loss
|
$ -8.68M
|
$ -2.28M
|
$ -1.58M
|
|
Operating Income / Loss
|
$ -8.85M
|
$ -2.35M
|
$ -1.62M
|
|
Cost of Revenue
|
$ .05M
|
$ M
|
$ .02M
|
|
Net Cash Flow
|
$ .51M
|
$ .02M
|
$ M
|
|
PE Ratio
|
|
|
|
|
|
|